✦ New

Tesamorelin

TH9507, Tesamorelin acetate, Egrifta (reference)

5mg≥99% HPLCLyophilized Powder

Tesamorelin is a stabilized synthetic analog of growth-hormone-releasing hormone (GHRH), referenced in preclinical literature studying the somatotropic axis and adipose-tissue metabolism. Supplied as a lyophilized powder for in-vitro laboratory use only.

$50.00

🧬 Triple Stack: buy 2, your 3rd Tesamorelin is free — applied automatically.

🔬 3rd-party tested📄 CoA per lot❄️ Cold-chain🇺🇸 USA made

For in-vitro research use only. Not approved by the FDA for human or animal use. No dosing, injection, or usage guidance is provided. Purchasers must be 21+ qualified researchers.

Description

Studies have used GHRH analogs of this class as reference ligands when characterizing GHRH-receptor signaling in isolated cell systems.

Metabolic ResearchGHRH Signaling

Product Specifications

Purity≥99%

Quantity5mg

FormLyophilized Powder

CAS Number218949-48-5

Molar Mass5135.9 g/mol

Mol. FormulaC221H366N72O67S

SolubilityReadily soluble in bacteriostatic or sterile water

Catalog No.CR-TESA-5

SequenceTrans-3-hexenoyl-modified 44-amino-acid GHRH(1–44) analog

Research Notes

GHRH Receptor Signaling

Referenced in in-vitro assays characterizing GHRH-receptor binding and downstream somatotropic signaling in isolated preparations.

Adipose Metabolism Models

Studied in cell-culture models of lipid metabolism. In-vitro findings do not predict in-vivo or clinical outcomes.

Handling

Handle with appropriate laboratory PPE.
Reconstitute with sterile or bacteriostatic water down the vial wall; swirl gently, never shake.
For qualified laboratory personnel in controlled settings only.

Storage

Store lyophilized powder at -4°F (-20°C) for long-term stability; stable refrigerated short-term.
Refrigerate reconstituted solution at 36–46°F (2–8°C) and protect from light.
Avoid repeated freeze–thaw cycles and heat exposure.